Fate Therapeutics, Inc. (FATE)
1.17
0.00 (0.00%)
USD |
NASDAQ |
Mar 13, 16:00
1.165
0.00 (0.00%)
After-Hours: 20:00
Fate Therapeutics Market Cap : 136.03M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MannKind Corp. | 853.44M |
| Vertex Pharmaceuticals, Inc. | 119.23B |
| Ardelyx, Inc. | 1.418B |
| ACADIA Pharmaceuticals, Inc. | 3.514B |
| Alnylam Pharmaceuticals, Inc. | 41.57B |
Market Cap Related Metrics
| PS Ratio | 20.91 |
| Price to Book Value | 0.6566 |
| Price | 1.17 |
| Earnings Yield | -98.09% |